The Kaplan–Meier analysis results showed that both OS and DFS time were significantly shorter in patients with high-PGAM1-expression than in patients with low-PGAM1-expression in almost all NSCLC cohorts (Fig. 1e–i). This evidence concerns the gene PGAM1 and non-small cell lung carcinoma.